Dec 16, 2021 / 10:00PM GMT
Operator
Greetings. Welcome to the Navidea Biopharmaceuticals Business Update Conference Call. (Operator Instructions)
I will now turn the conference over to your host Mike Rosol, Chief Medical Officer, you may begin.
Michael Stanley Rosol - Navidea Biopharmaceuticals, Inc. - Senior VP & Chief Medical Officer
Thank you. This call is being webcast live on our website ir.navidea.com and a replay will be made available. Following prepared remarks, we will be conducting an open question-and-answer segment, moderated by the Chair of our Board of Directors. Mr. Alex Cappello, joined by the Vice-Chair. Mr. Kim Scott and me, Mike Rosol.
During the course of this conference call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Navidea's molecular diagnostics and immunotherapeutics, which include clinical and regulatory developments and timing of clinical data readouts, along with capital resources and strategic matters, as well as the impact
Navidea Biopharmaceuticals Inc At Business Update Call Transcript
Dec 17, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers